Wolfgang Dummer

Blockade of CD11a by efalizumab in psoriasis patients induces a unique state of T-cell hyporesponsiveness.

James G Krueger, Kathy Howell, Y. Vugmeyster, 2008, The Journal of investigative dermatology.